AHL
VCYT icon

Abel Hall LLC’s Veracyte VCYT Stock Holding History

Abel Hall LLC’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$369K Buy
+6,282
New +$263K 0.06% 377

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Abel Hall LLC's VCYT Position: Q2 2026 in Review

Abel Hall LLC opened a new position in Veracyte (VCYT) in Q2 2026: 6,282 shares worth $369K. The stake represents 0.06% of the portfolio and ranks #377 among its holdings.

369 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Abel Hall LLC held 6,282 shares of Veracyte worth $369K as of Q2 2026.
  • Veracyte was a new Abel Hall LLC position in Q2 2026.
  • Veracyte made up 0.06% of Abel Hall LLC's portfolio in Q2 2026, its #377 holding.
  • 369 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.